文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

心脏骤停后动脉pCO2与etCO2的差值——结局预测因子还是不利复苏情况的标志物?

The difference between arterial pCO2 and etCO2 after cardiac arrest - Outcome predictor or marker of unfavorable resuscitation circumstances?
PubMed 文献 · Am J Emerg Med · 2022-09-06
一句话结论心脏骤停复苏成功后入院时ΔCO2较高与30天神经功能结局较差相关,但校正复苏时长或肾上腺素累积剂量后该关联消失,提示ΔCO2可能更多反映不利复苏情况而非独立预测因子。

该回顾性分析纳入2018年非创伤性院内外心脏骤停且复苏成功、已建立高级气道的128例成人患者,记录入院后首次动脉pCO2与采血时etCO2并计算ΔCO2(pCO2−etCO2),按中位数分为低ΔCO2组和高ΔCO2组。主要终点为30天神经功能良好(CPC 1-2),次要终点为30天生存。30天神经功能良好者ΔCO2较低(12.2 mmHg vs 18.8 mmHg,p=0.009),30天生存者ΔCO2亦较低(12.5 mmHg vs 20.0 mmHg,p=0.001)。粗二元logistic回归中ΔCO2与30天神经功能结局相关(OR=1.041/mmHg,95%CI 1.008-1.074,p=0.014),校正年龄、性别、目击骤停和可电击初始心律后仍存在,但加入复苏时长或肾上腺素累积剂量后关联消失。作者认为ΔCO2可能是不利复苏情况的替代标志物而非独立结局预测因子。

要点

  • 30天神经功能良好(CPC 1-2)者入院ΔCO2较低:12.2 mmHg vs 18.8 mmHg,p=0.009。
  • 30天生存者入院ΔCO2较低:12.5 mmHg vs 20.0 mmHg,p=0.001。
  • 粗分析中ΔCO2与30天神经功能结局相关:OR=1.041/mmHg,95%CI 1.008-1.074,p=0.014。
  • 校正年龄、性别、目击骤停、可电击初始心律后关联仍存在,但加入复苏时长或肾上腺素累积剂量后消失。
  • 高ΔCO2组心脏病因骤停较少,BMI更高、复苏时长更长、肾上腺素量更多、pO2更低而pCO2和血乳酸更高,血pH和HCO3-更低。

适用人群与场景

  • 2018年本院复苏数据库中的非创伤性院内外心脏骤停成人患者(≥18岁),且已建立高级气道、有完整数据集并恢复自主循环。
  • 排除:无高级气道管理、数据集不完整或未恢复自主循环的患者。

诊断标准与关键阈值

  • ΔCO2 = 入院后首次动脉pCO2 − 采血时etCO2(mmHg)。
  • 基线分析按ΔCO2中位数二分分为低ΔCO2组和高ΔCO2组。
  • 主要终点:30天神经功能良好,定义为脑功能分级(CPC)1-2。
  • 次要终点:30天生存。

研究设计与关键结果

  • 回顾性分析,302例筛查患者中128例符合分析条件。
  • 30天神经功能良好者ΔCO2为12.2 mmHg vs 18.8 mmHg,p=0.009。
  • 30天生存者ΔCO2为12.5 mmHg vs 20.0 mmHg,p=0.001。
  • 高ΔCO2组心脏病因骤停较少见,BMI更高,复苏时长更长,肾上腺素用量更多,pO2更低,但pCO2和血乳酸更高,入院时血pH和HCO3-更低。
  • 粗二元logistic回归:ΔCO2与30天神经功能结局相关,OR=1.041/mmHg(95%CI 1.008-1.074),p=0.014。
  • 校正年龄、性别、目击骤停和可电击初始心律后,ΔCO2与30天神经功能结局的关联持续存在。
  • 在模型中加入复苏时长或肾上腺素累积剂量后,ΔCO2失去关联。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,心脏骤停成功复苏后入院时ΔCO2与30天神经功能良好生存相关,但较高的ΔCO2可能更多是不利复苏情况的替代标志物,而非独立的结局预测因子。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: In former studies, the arterio-alveolar carbon dioxide gradient (ΔCO2) predicted in-hospital mortality after initially survived cardiac arrest. As early outcome predictors are urgently needed, we evaluated ΔCO2 as predictor for good neurological outcome in our cohort.

METHODS: We retrospectively analyzed all patients ≥18 years of age after non-traumatic in- and out of hospital cardiac arrest in the year 2018 from our resuscitation database. Patients without advanced airway management, incomplete datasets or without return of spontaneous circulation were excluded. The first arterial pCO2 after admission and the etCO2 in mmHg at the time of blood sampling were recorded from patient's charts. We then calculated ΔCO2 (pCO2 - etCO2). For baseline analyses, ΔCO2 was dichotomized into a low and high group with separation at the median. Good neurological outcome on day 30, expressed as Cerebral Performance Category 1-2, defined our primary endpoint. Survival to 30 days was used as secondary endpoint.

RESULTS: Out of 302 screened patients, 128 remained eligible for analyses. ΔCO2 was lower in 30-day survivors with good neurological outcome (12.2 mmHg vs. 18.8 mmHg, p = 0.009) and in 30-day survivors (12.5 mmHg vs. 20.0 mmHg, p = 0.001). In patients with high ΔCO2, a cardiac etiology of arrest was found less often. They had a higher body mass index, longer duration of resuscitation, higher amounts of epinephrine, lower pO2 levels but both higher pCO2 and blood lactate levels, resulting in lower blood pH and HCO3- levels at admission. In a crude binary logistic regression analysis, ΔCO2 was associated with 30-day neurological outcome (OR = 1.041 per mmHg of ΔCO2, 95% CI 1.008-1.074, p = 0.014). This association persisted after the adjustment for age, sex, witnessed arrest and shockable first rhythm. However, after addition of the duration of resuscitation or the cumulative epinephrine dosage to the model, ΔCO2 lost its association.

CONCLUSION: ΔCO2 at admission after a successfully resuscitated cardiac arrest is associated with 30 days survival with good neurological outcome. However, a higher ΔCO2 may rather be a surrogate for unfavorable resuscitation circumstances than an independent outcome predictor.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Mueller M, Jankow E, Grafeneder J, et al. The difference between arterial pCO2 and etCO2 after cardiac arrest - Outcome predictor or marker of unfavorable resuscitation circumstances? Am J Emerg Med. 2022. PMID: 36096013. doi:10.1016/j.ajem.2022.08.058

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。